KALOFONOS ISABEL (Chief Commercial Officer) reported 2 transactions at CRINETICS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/1/2026ACC: 0001628280-26-059885
Officer· Chief Commercial Officer
Since Feb 2026
-188.17K
Net shares
Net seller
$3.03M
Total sold
0
Open market trades
0B · 0S
4
Total transactions
188.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.67K
Price / share
$85.00
Trade value
$141.87K
% of position
4.7%
9/1/2026
35.67K→34K
Common Stock
Direct
Shares
−34K
Price / share
$85.00
Trade value
$2.89M
% of position
New position
9/1/2026
34K→0.00
Total
Net shares
−35.67K
Net value
-$3.03M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | D · Disposition | −1.67K | $85.00 | $141.87K | 4.7% | 35.67K | 34K |
| Common Stock Direct | 9/1/2026 | D · Disposition | −34K | $85.00 | $2.89M | New position | 34K | 0.00 |
| Total | −35.67K | -$3.03M | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
97.50K shares
Shares
−97.50K
Strike price
40.59
Held after
0.00
Exercisable
—
9/1/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
55K shares
Shares
−55K
Strike price
43.79
Held after
0.00
Exercisable
—
9/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock97.50K shares | 9/1/2026 | D · Disposition | −97.50K | 40.59 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock55K shares | 9/1/2026 | D · Disposition | −55K | 43.79 | — | 0.00 |